/

IRIX

IRIDEX CorporationPre-market

0.8483−0.08 −8.69%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delay

Open

0.9489

Prev close

0.9290

Day range

0.82010.9489

52-week range

0.61001.65

Volume

184.86K0.46×

Mkt cap

14.90M

P/E ttm

—

Fwd P/E

—

EPS ttm

-0.2000

Div yield

0.00%

Earnings

Aug 18, 2026

From 52w high

−48.59%

Price Chart

Yahoo Finance · delayed

IRIXOct 13, 2026O 0.9500H 0.9500L 0.8200C 0.8500−0.0800 (−8.60%)Vol 185.50K

SMA 500.7388
SMA 2001.0696

1Y change −19.05% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

IRIX IRIDEX Corporation · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +25.00%
1 month: +28.79%
3 months: −20.56%
6 months: −17.48%
Year to date: −25.44%
1 year: −19.05%

Valuation & ownership

Market cap: 14.90M
Enterprise value: 20.23M
P/E (ttm): —
Forward P/E: —
PEG ratio: 0.94
Price / book: —
Price / sales (ttm): 0.29
EV / EBITDA: -7.77
EPS (ttm): -0.2000
EPS (forward): 0.000000
Beta (5y monthly): 0.67
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 17.56M
Float: 5.16M
Short % of float: 1.18%
Short ratio (days): 2.66
Held by insiders: 36.69%
Held by institutions: 19.46%
Avg volume (3m): 400.65K
50-day average: 0.7384
200-day average: 1.07
52-week change: −19.05%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 63.0
vs 50-day SMA: +15.05%
vs 200-day SMA: −20.53%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 9.46%
Realised vol (20d, ann.): 108.4%
From 52-week high: −48.48%
From 52-week low: +39.34%

ANR

Analyst Consensus

1 analysts

Consensus

—

Mean target

2.75

+224.18% implied

Low 2.75Median 2.75High 2.75

Recommendation trend

Now1 / 0 / 0

Buy / hold / sell counts

Financial Snapshot

Full statements →trailing twelve months

DES

About IRIDEX Corporation

Yahoo Finance profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Sector: Healthcare
Industry: Medical Devices
Employees: 93
Headquarters: Mountain View, CA, United States

SEAS

Seasonality · IRIX

2007–2026 · monthly returns

Strongest month Jan +7.06%Weakest month Oct −3.15%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	30.7	-6.0	-27.9	2.0	1.9	9.5	-28.7	-12.2	-12.5	34.7			−25.6%
2025	-2.4	-15.9	-28.3	20.2	-16.0	-12.0	50.0	1.5	-14.9	-7.9	-8.6	18.8	−32.1%
2024	0.4	-4.6	10.8	-4.4	-14.7	-11.1	-6.9	0.0	-12.9	-13.1	17.8	-6.1	−40.2%
2023	10.4	-1.4	-7.3	13.8	-6.9	0.9	-6.0	-18.6	53.0	29.1	-22.3	10.2	+39.8%
2022	-13.6	-15.5	3.8	-17.3	-21.9	-14.0	17.1	-13.6	-7.3	-6.6	7.6	-16.9	−67.1%
2021	83.3	27.8	14.8	27.4	-8.6	-10.2	-7.4	15.7	1.2	0.1	-18.5	-2.2	+143.4%
2020	21.1	4.8	-43.8	10.1	2.9	17.8	-4.7	2.5	-5.3	-9.2	-3.9	46.8	+12.6%
2019	0.6	-5.9	2.5	9.0	0.0	-8.5	-24.4	-27.3	-26.0	-4.3	23.7	1.8	−52.6%
2018	-3.4	-21.3	-1.2	-4.2	29.6	-2.0	12.8	15.9	-30.2	-18.3	-8.7	-0.8	−38.3%
2017	-0.8	13.5	-25.1	-4.0	-21.1	10.0	-5.0	-5.3	5.3	-9.3	2.4	-12.4	−45.8%
2016	3.7	5.8	0.3	12.0	20.5	7.2	9.6	-7.9	-2.9	-6.5	16.5	-11.0	+51.3%
2015	5.2	17.7	0.3	-8.0	-14.8	-1.6	-13.2	-6.1	13.2	5.5	19.2	-2.9	+8.0%
2014	-16.7	11.0	-5.0	-6.7	4.9	-4.9	-7.2	4.0	-12.7	10.1	9.1	2.3	−15.4%
2013	7.7	11.0	-4.5	14.6	17.3	-1.2	2.7	-0.2	-2.1	0.7	68.8	0.9	+160.8%
2012	4.3	4.6	8.1	-3.6	-4.2	2.5	-16.5	-0.9	7.2	7.6	0.5	-2.5	+4.3%
2011	2.6	-9.2	24.7	-11.2	-3.7	3.1	-1.5	1.3	-7.5	-7.8	7.6	1.9	−4.6%
2010	-2.6	-1.3	45.8	0.7	-8.3	-7.3	5.2	-25.3	19.4	4.3	0.8	8.0	+27.7%
2009	-17.6	11.4	46.2	24.6	34.5	7.9	6.3	5.0	4.3	-14.6	54.6	-3.2	+261.2%
2008	53.1	-14.7	-50.3	6.3	39.6	4.7	15.8	41.6	-15.6	-32.7	-60.9	-5.6	−65.3%
2007	-1.0	14.6	-12.5	-19.5	-22.2	-4.5	-41.3	23.9	12.3	13.0	-44.0	-9.9	−72.4%

INSD

Insider Activity · IRIX

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 15, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 0.63 per share.	7.9K	$4.98K
Sep 13, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 0.65 per share.	2.4K	$1.53K
Sep 9, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 0.68 per share.	5.1K	$3.47K
Jul 9, 2026	Dizon Romeo RChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	30K	—
Jul 9, 2026	Mercer PatrickChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	100K	—
Jun 11, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.14 per share.	975	$1.11K
Jun 10, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.14 per share.	1.7K	$1.91K
Jun 7, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.12 per share.	2.4K	$2.69K
Jun 4, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.15 per share.	2.5K	$2.90K
Jun 2, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.17 per share.	2.4K	$2.81K
May 25, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.00 per share.	5K	$5.00K
Mar 29, 2026	Lin Shih-Yao DavidBeneficial Owner of more than 10% of a Class of Security	Purchase at price 0.93 - 1.49 per share.	350.6K	$438.76K
Mar 5, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.26 per share.	1.1K	$1.40K
Feb 16, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.31 - 1.37 per share.	2.2K	$2.94K
Feb 11, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.43 per share.	1.5K	$2.15K
Feb 9, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.46 per share.	1K	$1.46K
Feb 2, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.38 per share.	2.5K	$3.45K
Jan 28, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.44 per share.	1.1K	$1.59K
Jan 27, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.46 per share.	1.3K	$1.90K
Jan 26, 2026	Dizon Romeo RChief Financial Officer	Purchase at price 1.48 per share.	3.4K	$5.01K

13F

Investors Holding IRIX

latest 13F filings of 29 followed managers

Investors holding IRIX
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$485.0K	0.00%	423.54K	+6.8%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

IRIX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

IRIX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About IRIDEX Corporation

Seasonality · IRIX

Insider Activity · IRIX

Congress Trades · IRIX

Investors Holding IRIX

Investors Holding IRIX

Congress Trades · IRIX

Insider Activity · IRIX

Seasonality · IRIX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About IRIDEX Corporation

Earnings & Dividends

News